Expiring federal contract · order under a contract vehicle
SPE2D026F0104 — Sagent Pharmaceuticals, INC
Department of Defense · Defense Logistics Agency
- Contract / PIID
- SPE2D026F0104
- Incumbent
- Sagent Pharmaceuticals, INC
- Incumbent UEI
- PR1HCLM3FMW7
- Current end date
- April 5, 2027
- Potential total value
- $148,765
- Obligated
- $148,765
- NAICS
- 325411 — Medicinal and Botanical Manufacturing
- PSC
- 6505 — DRUGS AND BIOLOGICALS
- Set-aside
- Not stated
- Start date
- February 25, 2026
- Place of performance
- IL
- Award type
- DELIVERY ORDER
Source: USASpending.gov award record, last checked November 22, 2026. Place of performance as reported by USASpending.
What the contract covers
8511940095!OTHER MEDICAL
Likely rebid window (estimate)
- Sources Sought / RFI: about Apr 2026 – Oct 2026 (6–12 months before the end date)
- RFP: about Dec 2026 – Feb 2027 (2–4 months before the end date)
Between the estimated Sources Sought and RFP windows.
This is an order under contract vehicle SPE2D021D0003. Orders are usually not competed on their own: the next order may be placed under the same vehicle.
Estimated from the current end date using typical federal recompete timing. Agencies set their own schedules, and contracts are often extended. This is not a published solicitation date.
Track this recompete free
- Change history: no changes recorded since Mindy began tracking this contract.
- Alerts: get an email when the end date moves or the follow-on is posted.
- Contacts: the buying office and small-business contacts for this agency.
Other contracts expiring at Department of Defense (NAICS 325411)
- SPE2D026F0011 — Johnson & Johnson Health Care Systems INC. · ends December 2, 2026 · $384K
- SPE2D026F0085 — Alcon Vision, LLC · ends March 29, 2027 · $115K
- SPE2D026F0101 — Bayer Healthcare Pharmaceuticals INC · ends April 5, 2027 · $120K
- SPE2D026F0105 — Eagle Pharmaceuticals, INC. · ends April 6, 2027 · $186K
- SPE2D026F0099 — Chartwell Rx LLC · ends April 19, 2027 · $649K
- SPE2D026F0203 — Medline Industries, LP · ends June 30, 2027 · $115K
- SPE2D025F0475 — Dental Health Products Incorporated · ends July 26, 2027 · $140K
- SPE2D026F0248 — Dental Health Products Incorporated · ends July 26, 2027 · $108K
- SPE2D026F0251 — Marlex Pharmaceuticals INC · ends August 9, 2027 · $100K
- SPE2D026F0278 — Fresenius Kabi, LLC · ends August 30, 2027 · $1.3M